Table 1.
The target trough levels of tacrolimus with and without mycophenolate mofetil (MMF) relative to the posttransplant period after adult living-donor liver transplantation. The values of calcineurin inhibitor (CNI)-sparing tacrolimus are comparable to the suggested CNI target levels for hepatocellular carcinoma patients beyond the Milan criteria